Literature DB >> 723151

Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites.

P J Somerville, M Kaye.   

Abstract

Resistance to the calcemic action of parathyroid extract (PTE) was shown in thyroparathyroidectomized rats after 5 hr of renal failure that was induced by either bilateral nephrectomy (NPX) or ureter ligation (UL). Studies were carried out to investigate the relationship of parathyroid resistance to the vitamin D status of the animal. Concentrations of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 24,25-dihydroxycholecalciferol (24,25(OH)2D3) were similar in pooled sera samples from rats either UL or sham-operated and treated with PTE. Pretreatment with oral 25-hydroxycholecalciferol or with a combination of i.v. 24,25(OH)2D3 and 1,25(OH)2D3 prior to UL failed to alter the resistance. Resistance was also present in a group in vitamin-D-deficient rats. A similar group given 1 microgram of vitamin D2 showed more parathyroid resistance than did the group not given vitamin D2. In chronic renal failure of 28 day's duration, parathyroid resistance was again demonstrated, but, in contrast to the acute renal failure models, this was partly corrected by prior 1,25(OH)2D3 administration. These studies show that parathyroid resistance is not caused by an abnormality of vitamin D metabolism in the acute renal failure model, and we suggest that the phenomenon is due to the accumulation of one or more uremic factors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 723151     DOI: 10.1038/ki.1978.116

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

Review 1.  Vitamin D and analogues in renal bone disease and implications for osteoporosis.

Authors:  J A Kanis; E V McCloskey; M N Beneton
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.

Authors:  S Lopez-Hilker; T Galceran; Y L Chan; N Rapp; K J Martin; E Slatopolsky
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

3.  Abnormal skeletal response to parathyroid hormone in dogs with chronic uremia.

Authors:  K Olgaard; M Arbelaez; J Schwartz; S Klahr; E Slatopolsky
Journal:  Calcif Tissue Int       Date:  1982-07       Impact factor: 4.333

4.  [Hyperparathyroidism in hemodialysis patients: studies on parathyroid regulation and classification problems (author's transl)].

Authors:  R Augustin; W H Hackeng
Journal:  Klin Wochenschr       Date:  1981-11-16

Review 5.  Abnormal skeletal response to parathyroid hormone and the expression of its receptor in chronic uremia.

Authors:  T B Drüeke
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

6.  Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure.

Authors:  N A Hamdy; J A Kanis; M N Beneton; C B Brown; J R Juttmann; J G Jordans; S Josse; A Meyrier; R L Lins; I T Fairey
Journal:  BMJ       Date:  1995-02-11

7.  Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.

Authors:  Kenneth R Phelps
Journal:  Nutrients       Date:  2017-04-26       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.